MarketInOut Stock Screener Log In | Sign Up
 

Immucell Corp

NASDAQ • Healthcare • Biotechnology • Quote as of 07/24/2026
Immucell Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization101.28 mln
Float6.00 mln
Earnings Date08/13/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.08
Reliable

Relative Strength

83 / 100
Strongly outperforming

Debt / Equity

0.44
Low leverage

Pre-Tax Margin

8%
Moderate margin

ROE

-1.88
Negative

Business Description

ImmuCell Corporation is a Maine-based animal health company that develops and sells products designed to improve the health and output of dairy and beef cattle across the United States and in other countries. Its core offerings help prevent and treat two major cattle health problems: scours, a common and potentially fatal digestive illness in calves, and mastitis, an udder infection that reduces milk quality and output in dairy cows. The company also has a treatment in development that uses a natural compound called Nisin to address a form of mastitis that shows no outward symptoms but still harms milk production. ImmuCell reaches its customers through animal health distributors and has been operating since 1982.

Key Fundamentals

EPS-0.07
ROE-1.88
RPS3.31
ROIC6.64
ROA-1.21
Interest Cover5.82
EBITDA, mln2.49
EV / EBITDA38.00
EV / EBIT-1,016
Revenue, mln29.93
EV / Revenue3.16

Financial Strength

Altman Z-Score4.21
Piotroski F-Score 6 / 9
Beneish M-Score-3.08
Price to Intrinsic Value39.98
Price to Graham Number3.09
Short Ratio0.74
Short % of Float0.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.9% 45 / 100   
1 Month 12.67% 92 / 100   
2 Months 46.29% 96 / 100   
6 Months 68.14% 97 / 100   
1 Year 58.71% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us